Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.
This article will review the published research on the elucidation of the mechanisms of pituitary adenoma formation. Mass spectrometry (MS) plays a key role in those studies. Comparative proteomics has been used with the long-term goal to locate, detect, and characterize the differentially expressed proteins (DEPs) in human pituitary adenomas; to identify tumor-related and -specific biomarkers; and to clarify the basic molecular mechanisms of pituitary adenoma formation. The methodology used for comparative proteomics, the current status of human pituitary proteomics studies, and future perspectives are reviewed. The methodologies that are used in comparative proteomics studies of human pituitary adenomas are readily exportable to other different areas of cancer research.
Zhan
Xianquan
X
Charles B. Stout Neuroscience Mass Spectrometry Laboratory, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Desiderio
Dominic M
DM
D000236:Adenoma / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000032:analysis / Q000737:chemistry* / Q000378:metabolism; D020869:Gene Expression Profiling / Q000379:methods* / Q000639:trends; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods* / Q000639:trends; D009363:Neoplasm Proteins / Q000032:analysis / Q000737:chemistry* / Q000378:metabolism; D010911:Pituitary Neoplasms / Q000378:metabolism*; D040901:Proteomics / Q000379:methods* / Q000639:trends; D013329:Structure-Activity Relationship
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins